149 related articles for article (PubMed ID: 33002819)
1. The optimal timing for the interval to surgery after short course preoperative radiotherapy (5 ×5 Gy) in rectal cancer - are we too eager for surgery?
Glynne-Jones R; Hall M; Nagtegaal ID
Cancer Treat Rev; 2020 Nov; 90():102104. PubMed ID: 33002819
[TBL] [Abstract][Full Text] [Related]
2. Should we favour the use of 5 × 5 preoperative radiation in rectal cancer.
Kane C; Glynne-Jones R
Cancer Treat Rev; 2019 Dec; 81():101908. PubMed ID: 31683174
[TBL] [Abstract][Full Text] [Related]
3. Short course preoperative radiotherapy is the single most important risk factor for perineal wound complications after abdominoperineal excision of the rectum.
Chadwick MA; Vieten D; Pettitt E; Dixon AR; Roe AM
Colorectal Dis; 2006 Nov; 8(9):756-61. PubMed ID: 17032320
[TBL] [Abstract][Full Text] [Related]
4. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial.
Zhang MX; Li XB; Guan BJ; Guan GX; Lin XY; Wu XD; Chi P; Xu BH
BMJ Open; 2019 Mar; 9(3):e025944. PubMed ID: 30904869
[TBL] [Abstract][Full Text] [Related]
5. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
Erlandsson J; Holm T; Pettersson D; Berglund Å; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallböök O; Syk I; Glimelius B; Martling A
Lancet Oncol; 2017 Mar; 18(3):336-346. PubMed ID: 28190762
[TBL] [Abstract][Full Text] [Related]
6. Preoperative radiotherapy 5 × 5 Gy and short versus long interval between surgery for resectable rectal cancer: 10-Year follow-up of the randomised controlled trial.
Pach R; Sierzega M; Szczepanik A; Popiela T; Richter P
Radiother Oncol; 2021 Nov; 164():268-274. PubMed ID: 34653526
[TBL] [Abstract][Full Text] [Related]
7. Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer.
Gollins S
Colorectal Dis; 2010 Aug; 12 Suppl 2():2-24. PubMed ID: 20618363
[TBL] [Abstract][Full Text] [Related]
8. Alternative clinical end points in rectal cancer--are we getting closer?
Glynne-Jones R; Mawdsley S; Pearce T; Buyse M
Ann Oncol; 2006 Aug; 17(8):1239-48. PubMed ID: 16873440
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant radiotherapy (5 × 5 Gy): immediate versus delayed surgery.
Bujko K; Partycki M; Pietrzak L
Recent Results Cancer Res; 2014; 203():171-87. PubMed ID: 25103005
[TBL] [Abstract][Full Text] [Related]
10. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].
Créhange G; Bosset JF; Maingon P
Cancer Radiother; 2011 Oct; 15(6-7):440-4. PubMed ID: 21802334
[TBL] [Abstract][Full Text] [Related]
11. Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer.
Kaytan-Saglam E; Balik E; Saglam S; Akgün Z; Ibis K; Keskin M; Dagoglu N; Kapran Y; Gulluoglu M
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1597-1603. PubMed ID: 28374169
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation?
Glynne-Jones R; Anyamene N; Moran B; Harrison M
Ann Oncol; 2012 Oct; 23(10):2517-2526. PubMed ID: 22367706
[TBL] [Abstract][Full Text] [Related]
13. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
Klenova A; Georgiev R; Kurtev P; Kurteva G
J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials.
Colorectal Cancer Collaborative Group
Lancet; 2001 Oct; 358(9290):1291-304. PubMed ID: 11684209
[TBL] [Abstract][Full Text] [Related]
15. What is the optimal timing of surgery after short-course radiotherapy for rectal cancer?
Donnelly SM; Wyatt J; Powell SG; Jones N; Altaf K; Ahmed S
Surg Oncol; 2023 Dec; 51():101992. PubMed ID: 37757518
[TBL] [Abstract][Full Text] [Related]
16. Point: short-course radiation therapy is preferable in the neoadjuvant treatment of rectal cancer.
Bujko K; Bujko M
Semin Radiat Oncol; 2011 Jul; 21(3):220-7. PubMed ID: 21645867
[TBL] [Abstract][Full Text] [Related]
17. A systematic overview of radiation therapy effects in rectal cancer.
Glimelius B; Grönberg H; Järhult J; Wallgren A; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):476-92. PubMed ID: 14596508
[TBL] [Abstract][Full Text] [Related]
18. Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study.
Ciseł B; Pietrzak L; Michalski W; Wyrwicz L; Rutkowski A; Kosakowska E; Cencelewicz A; Spałek M; Polkowski W; Jankiewicz M; Styliński R; Bębenek M; Kapturkiewicz B; Maciejczyk A; Sadowski J; Zygulska J; Zegarski W; Jankowski M; Las-Jankowska M; Toczko Z; Żelazowska-Omiotek U; Kępka L; Socha J; Wasilewska-Tesluk E; Markiewicz W; Kładny J; Majewski A; Kapuściński W; Suwiński R; Bujko K;
Ann Oncol; 2019 Aug; 30(8):1298-1303. PubMed ID: 31192355
[TBL] [Abstract][Full Text] [Related]
19. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.
van Gijn W; van Stiphout RGPM; van de Velde CJH; Valentini V; Lammering G; Gambacorta MA; Påhlman L; Bujko K; Lambin P
Ann Oncol; 2015 May; 26(5):928-935. PubMed ID: 25609247
[TBL] [Abstract][Full Text] [Related]
20. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer.
De Haas-Kock DF; Buijsen J; Pijls-Johannesma M; Lutgens L; Lammering G; van Mastrigt GA; De Ruysscher DK; Lambin P; van der Zee J
Cochrane Database Syst Rev; 2009 Jul; (3):CD006269. PubMed ID: 19588384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
